CART Infusion

BIOLOGICAL3 trials

Sponsors

National University Hospital, Singapore, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Kure Cells, INC

Conditions

Autoimmune Hemolytic AnemiaB-cell Lymphoma RefractoryCAR T Cell TherapyDiffuse Large B Cell Lymphoma (DLBCL)Evans SyndromeFollicular B-cell Non-Hodgkin's LymphomaLymphoma NonhodgkinMarginal Zone B Cell Lymphoma

Early Phase 1

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

RecruitingNCT07441525

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAutoimmune Hemolytic Anemia, Evans Syndrome, Primary Immune Thrombocytopenic Purpura

Start: 2026-02-03End: 2029-06-30Target: 27Updated: 2026-03-02

Phase 1

Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

RecruitingNCT07319676

National University Hospital, SingaporeB-cell Lymphoma Refractory

Start: 2026-03-02End: 2040-10-31Target: 30Updated: 2026-04-09

Phase 2

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Not yet recruitingNCT07713459

Kure Cells, INCCAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma +2

Start: 2026-08-31End: 2029-11-30Target: 105Updated: 2026-07-20